Repro Med Systems Inc
NASDAQ:KRMD

Watchlist Manager
Repro Med Systems Inc Logo
Repro Med Systems Inc
NASDAQ:KRMD
Watchlist
Price: 3.96 USD -0.75% Market Closed
Market Cap: $183.6m

Repro Med Systems Inc
Revenue

Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Quarterly
Annual
TTM
|
See Also

Repro Med Systems Inc
Revenue Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Revenue CAGR 3Y CAGR 5Y CAGR 10Y
Repro Med Systems Inc
NASDAQ:KRMD
Revenue
$41.1m
CAGR 3-Years
14%
CAGR 5-Years
11%
CAGR 10-Years
13%
Boston Scientific Corp
NYSE:BSX
Revenue
$20.1B
CAGR 3-Years
17%
CAGR 5-Years
15%
CAGR 10-Years
10%
Edwards Lifesciences Corp
NYSE:EW
Revenue
$6.1B
CAGR 3-Years
11%
CAGR 5-Years
7%
CAGR 10-Years
9%
Stryker Corp
NYSE:SYK
Revenue
$25.1B
CAGR 3-Years
11%
CAGR 5-Years
12%
CAGR 10-Years
10%
Abbott Laboratories
NYSE:ABT
Revenue
$45.1B
CAGR 3-Years
3%
CAGR 5-Years
4%
CAGR 10-Years
8%
Intuitive Surgical Inc
NASDAQ:ISRG
Revenue
$10.1B
CAGR 3-Years
17%
CAGR 5-Years
18%
CAGR 10-Years
15%
No Stocks Found

Repro Med Systems Inc
Glance View

Market Cap
183.6m USD
Industry
Health Care

Repro-Med Systems, Inc. engages in the design, manufacture, and market of proprietary medical devices. The company is headquartered in Chester New York, New York and currently employs 77 full-time employees. The company is focused on the developing, manufacturing, and commercializing of specialty infusion solutions. The firm's products include the FREEDOM Infusion Systems, which consist of the FREEDOM60 Syringe Driver, the FreedomEdge Syringe Driver, HIgHFlo Subcutaneous Safety Needle Sets and Precision Flow Rate Tubing. The FREEDOM System operates at a lower pressure and maintains a balance between what a patient’s subcutaneous tissues can absorb and what the system delivers. The firm performs product assembly, calibration, pre- and post-assembly quality control inspection and testing, and final packaging for all its products at its Chester, New York facility.

KRMD Intrinsic Value
2.45 USD
Overvaluation 38%
Intrinsic Value
Price $3.96

See Also

What is Repro Med Systems Inc's Revenue?
Revenue
41.1m USD

Based on the financial report for Dec 31, 2025, Repro Med Systems Inc's Revenue amounts to 41.1m USD.

What is Repro Med Systems Inc's Revenue growth rate?
Revenue CAGR 10Y
13%

Over the last year, the Revenue growth was 22%. The average annual Revenue growth rates for Repro Med Systems Inc have been 14% over the past three years , 11% over the past five years , and 13% over the past ten years .

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett